Health care companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 140 health care companies in the United States ranked by one-year price change, at +740%, ahead of Erasca (+387%) and Kodiak Sciences (+371%). Figures as of 21 Nov 2026, 06:00 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 140
- First
- Moderna+740%
- Median
- +22.1%
- Combined market value
- NOK 71.18T
- Countries
- 1
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +740% | NOK 769.2B | NOK 1,901.13 | 2.17% down | 740% up | ||
| 2 | ErascaERAS · Health Care | +387% | NOK 46.6B | NOK 132.69 | 4.29% down | 387% up | ||
| 3 | Kodiak SciencesKOD · Health Care | +371% | NOK 62B | NOK 947.35 | 0.75% down | 371% up | ||
| 4 | Spyre TherapeuticsSYRE · Health Care | +302% | NOK 86.5B | NOK 911.28 | 4.26% down | 302% up | ||
| 5 | Twist BioscienceTWST · Health Care | +291% | NOK 68.7B | NOK 1,007.31 | 7.44% down | 291% up | ||
| 6 | Oruka TherapeuticsORKA · Health Care | +233% | NOK 63.4B | NOK 934.09 | 1.80% down | 233% up | ||
| 7 | VeradermicsMANE · Health Care | +230% | NOK 49.2B | NOK 1,165.25 | 3.92% down | 230% up | ||
| 8 | ImmunityBioIBRX · Health Care | +216% | NOK 62.4B | NOK 58.69 | 8.37% down | 216% up | ||
| 9 | 10x GenomicsTXG · Health Care | +213% | NOK 66.4B | NOK 505.02 | 9.72% down | 213% up | ||
| 10 | Definium TherapeuticsDFTX · Health Care | +176% | NOK 37.8B | NOK 276.30 | 3.87% down | 176% up | ||
| 11 | GlaukosGKOS · Health Care | +139% | NOK 137B | NOK 2,313.63 | 0.33% down | 139% up | ||
| 12 | Revolution MedicinesRVMD · Health Care | +125% | NOK 339.9B | NOK 1,571.60 | 1.11% up | 125% up | ||
| 13 | LifeStance Health GroupLFST · Health Care | +107% | NOK 51.2B | NOK 134.74 | 3.60% up | 107% up | ||
| 14 | Concentra Group Holdings ParentCON · Health Care | +105% | NOK 51.3B | NOK 407.91 | 0.94% up | 105% up | ||
| 15 | Dianthus TherapeuticsDNTH · Health Care | +105% | NOK 46.4B | NOK 824.31 | 0.33% down | 105% up | ||
| 16 | TG TherapeuticsTGTX · Health Care | +103% | NOK 93.3B | NOK 617.53 | 2.37% down | 103% up | ||
| 17 | Charles River Laboratories InternationalCRL · Health Care | +95.6% | NOK 146.8B | NOK 3,064.43 | 4.15% down | 96% up | ||
| 18 | Oscar HealthOSCR · Health Care | +94.1% | NOK 74.9B | NOK 241.10 | 5.50% down | 94% up | ||
| 19 | CG OncologyCGON · Health Care | +93.0% | NOK 69.2B | NOK 774.78 | 2.97% down | 93% up | ||
| 20 | ViatrisVTRS · Health Care | +90.1% | NOK 219.4B | NOK 191.38 | 1.26% down | 90% up | ||
| 21 | BrightSpring Health ServicesBTSG · Health Care | +85.1% | NOK 122B | NOK 613.14 | 1.77% down | 85% up | ||
| 22 | Praxis Precision MedicinesPRAX · Health Care | +83.1% | NOK 81.9B | NOK 2,929.01 | 3.37% down | 83% up | ||
| 23 | Lantheus HoldingsLNTH · Health Care | +82.9% | NOK 65.1B | NOK 995.41 | 0.00% | 83% up | ||
| 24 | Edgewise TherapeuticsEWTX · Health Care | +81.6% | NOK 42.6B | NOK 389.05 | 3.07% down | 82% up | ||
| 25 | Kymera TherapeuticsKYMR · Health Care | +80.8% | NOK 96B | NOK 1,124.20 | 3.42% down | 81% up | ||
| 26 | CenteneCNC · Health Care | +79.7% | NOK 307.8B | NOK 621.82 | 2.74% down | 80% up | ||
| 27 | Amneal PharmaceuticalsAMRX · Health Care | +79.0% | NOK 71.7B | NOK 205.91 | 1.26% down | 79% up | ||
| 28 | Royalty PharmaRPRX · Health Care | +74.0% | NOK 383.7B | NOK 667.35 | 1.08% up | 74% up | ||
| 29 | HumanaHUM · Health Care | +67.3% | NOK 456.7B | NOK 3,802.27 | 2.63% up | 67% up | ||
| 30 | IlluminaILMN · Health Care | +62.0% | NOK 284.2B | NOK 1,879.88 | 3.90% down | 62% up | ||
| 31 | PACS GroupPACS · Health Care | +56.5% | NOK 67.6B | NOK 425.76 | 1.49% up | 56% up | ||
| 32 | ExelixisEXEL · Health Care | +54.9% | NOK 153.8B | NOK 630.10 | 1.82% down | 55% up | ||
| 33 | RevvityRVTY · Health Care | +54.3% | NOK 158.1B | NOK 1,415.81 | 4.20% down | 54% up | ||
| 34 | HaemoneticsHAE · Health Care | +52.8% | NOK 53.3B | NOK 1,171.49 | 0.17% down | 53% up | ||
| 35 | Adaptive BiotechnologiesADPT · Health Care | +50.7% | NOK 44.1B | NOK 272.30 | 0.43% down | 51% up | ||
| 36 | Krystal BiotechKRYS · Health Care | +49.0% | NOK 89.2B | NOK 3,011.49 | 2.19% down | 49% up | ||
| 37 | TeleflexTFX · Health Care | +48.2% | NOK 62.5B | NOK 1,575.31 | 1.11% down | 48% up | ||
| 38 | West Pharmaceutical ServicesWST · Health Care | +46.3% | NOK 265.1B | NOK 3,805.19 | 1.61% down | 46% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | +45.2% | NOK 77.3B | NOK 1,183.58 | 2.11% down | 45% up | ||
| 40 | HeartflowHTFL · Health Care | +44.7% | NOK 40B | NOK 455.20 | 4.62% up | 45% up | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | +44.0% | NOK 55.9B | NOK 2,796.62 | 0.03% down | 44% up | ||
| 42 | ImmunovantIMVT · Health Care | +44.0% | NOK 64.1B | NOK 309.74 | 2.31% down | 44% up | ||
| 43 | Molina HealthcareMOH · Health Care | +43.6% | NOK 101B | NOK 1,934.18 | 2.43% down | 44% up | ||
| 44 | BiogenBIIB · Health Care | +41.0% | NOK 359.7B | NOK 2,433.35 | 1.00% up | 41% up | ||
| 45 | Becton, DickinsonBDX · Health Care | +40.4% | NOK 565.1B | NOK 2,074.48 | 0.05% up | 40% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | +39.2% | NOK 44B | NOK 458.22 | 2.69% down | 39% up | ||
| 47 | Labcorp HoldingsLH · Health Care | +38.9% | NOK 290.6B | NOK 3,579.30 | 0.47% down | 39% up | ||
| 48 | Baxter InternationalBAX · Health Care | +38.7% | NOK 128.1B | NOK 247.54 | 0.00% | 39% up | ||
| 49 | Guardant HealthGH · Health Care | +38.1% | NOK 192.3B | NOK 1,421.76 | 0.16% up | 38% up | ||
| 50 | Tenet HealthcareTHC · Health Care | +37.3% | NOK 204.2B | NOK 2,565.94 | 0.15% down | 37% up | ||
| 51 | Merck & CoMRK · Health Care | +35.9% | NOK 3.21T | NOK 1,303.69 | 0.69% up | 36% up | ||
| 52 | Quest DiagnosticsDGX · Health Care | +35.5% | NOK 277B | NOK 2,518.08 | 0.31% down | 35% up | ||
| 53 | Mirum PharmaceuticalsMIRM · Health Care | +34.6% | NOK 61.2B | NOK 937.21 | 0.65% up | 35% up | ||
| 54 | DexComDXCM · Health Care | +33.1% | NOK 288.4B | NOK 773.32 | 1.08% down | 33% up | ||
| 55 | Halozyme TherapeuticsHALO · Health Care | +32.3% | NOK 101.5B | NOK 890.61 | 1.82% down | 32% up | ||
| 56 | Gilead SciencesGILD · Health Care | +31.5% | NOK 2.01T | NOK 1,622.59 | 0.06% down | 31% up | ||
| 57 | BrukerBRKR · Health Care | +31.4% | NOK 84.1B | NOK 550.45 | 9.08% down | 31% up | ||
| 58 | AvantorAVTR · Health Care | +31.3% | NOK 98B | NOK 144.68 | 1.85% down | 31% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | +31.0% | NOK 6.35T | NOK 2,636.92 | 1.25% up | 31% up | ||
| 60 | DaVitaDVA · Health Care | +30.0% | NOK 98.7B | NOK 1,569.95 | 3.00% up | 30% up | ||
| 61 | Cardinal HealthCAH · Health Care | +30.0% | NOK 614.8B | NOK 2,659.73 | 0.17% up | 30% up | ||
| 62 | AmgenAMGN · Health Care | +30.0% | NOK 2.3T | NOK 4,247.23 | 0.15% down | 30% up | ||
| 63 | Eli LillyLLY · Health Care | +27.5% | NOK 11.7T | NOK 13,133.51 | 0.30% down | 28% up | ||
| 64 | Bristol-Myers SquibbBMY · Health Care | +26.1% | NOK 1.17T | NOK 573.26 | 0.79% up | 26% up | ||
| 65 | NateraNTRA · Health Care | +25.7% | NOK 386.5B | NOK 2,665.49 | 5.70% down | 26% up | ||
| 66 | Scholar Rock HoldingSRRK · Health Care | +25.3% | NOK 57.2B | NOK 469.24 | 4.45% down | 25% up | ||
| 67 | Belite BioBLTE · Health Care | +25.3% | NOK 50.4B | NOK 1,241.88 | 15.65% down | 25% up | ||
| 68 | ChemedCHE · Health Care | +24.8% | NOK 69.3B | NOK 5,348.42 | 0.50% down | 25% up | ||
| 69 | McKessonMCK · Health Care | +22.6% | NOK 1.2T | NOK 10,426.30 | 0.68% up | 23% up | ||
| 70 | Regeneron PharmaceuticalsREGN · Health Care | +22.2% | NOK 928.6B | NOK 8,976.18 | 0.19% down | 22% up | ||
| 71 | VaxcytePCVX · Health Care | +22.1% | NOK 85.5B | NOK 540.02 | 5.09% down | 22% up | ||
| 72 | Edwards LifesciencesEW · Health Care | +22.0% | NOK 571B | NOK 992.98 | 1.95% down | 22% up | ||
| 73 | Vertex PharmaceuticalsVRTX · Health Care | +22.0% | NOK 1.27T | NOK 5,021.14 | 1.08% down | 22% up | ||
| 74 | Elevance HealthELV · Health Care | +21.3% | NOK 830.9B | NOK 3,845.94 | 1.11% up | 21% up | ||
| 75 | AbbVieABBV · Health Care | +20.0% | NOK 4.93T | NOK 2,790.28 | 0.94% up | 20% up | ||
| 76 | Elanco Animal HealthELAN · Health Care | +18.2% | NOK 125.4B | NOK 250.95 | 2.09% down | 18% up | ||
| 77 | Bio-TechneTECH · Health Care | +18.2% | NOK 111.3B | NOK 708.49 | 0.04% down | 18% up | ||
| 78 | United TherapeuticsUTHR · Health Care | +17.7% | NOK 230.3B | NOK 5,408.28 | 0.78% down | 18% up | ||
| 79 | Mettler-Toledo InternationalMTD · Health Care | +17.4% | NOK 323.2B | NOK 16,251.08 | 2.27% down | 17% up | ||
| 80 | Thermo Fisher ScientificTMO · Health Care | +17.2% | NOK 2.42T | NOK 6,527.61 | 2.79% down | 17% up | ||
| 81 | Bio-Rad LaboratoriesBIO · Health Care | +16.0% | NOK 94.1B | NOK 3,499.06 | 2.34% down | 16% up | ||
| 82 | Agilent TechnologiesA · Health Care | +15.9% | NOK 468.4B | NOK 1,661.10 | 2.83% down | 16% up | ||
| 83 | WatersWAT · Health Care | +15.9% | NOK 843.9B | NOK 4,294.12 | 3.51% down | 16% up | ||
| 84 | Encompass HealthEHC · Health Care | +15.7% | NOK 127.9B | NOK 1,303.01 | 1.04% up | 16% up | ||
| 85 | Henry ScheinHSIC · Health Care | +15.5% | NOK 90B | NOK 814.27 | 1.51% down | 16% up | ||
| 86 | Rhythm PharmaceuticalsRYTM · Health Care | +14.8% | NOK 75.9B | NOK 1,095.44 | 3.80% down | 15% up | ||
| 87 | BridgeBio PharmaBBIO · Health Care | +14.8% | NOK 144.4B | NOK 741.25 | 2.75% down | 15% up | ||
| 88 | IncyteINCY · Health Care | +13.5% | NOK 227.8B | NOK 1,117.52 | 1.07% down | 14% up | ||
| 89 | MSA SafetyMSA · Health Care | +13.1% | NOK 63.9B | NOK 1,657.69 | 3.52% down | 13% up | ||
| 90 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | NOK 114.1B | NOK 588.96 | 1.64% down | 12% up | ||
| 91 | GRAILGRAL · Health Care | +12.1% | NOK 43.5B | NOK 967.63 | 5.33% down | 12% up | ||
| 92 | Align TechnologyALGN · Health Care | +12.0% | NOK 106.6B | NOK 1,512.81 | 2.82% down | 12% up | ||
| 93 | IQVIA HoldingsIQV · Health Care | +11.4% | NOK 395B | NOK 2,396.60 | 1.89% down | 11% up | ||
| 94 | PenumbraPEN · Health Care | +10.9% | NOK 122.6B | NOK 3,111.23 | 0.28% down | 11% up | ||
| 95 | Neurocrine BiosciencesNBIX · Health Care | +10.4% | NOK 148.6B | NOK 1,467.97 | 3.84% down | 10% up | ||
| 96 | Zimmer Biomet HoldingsZBH · Health Care | +10.1% | NOK 186.5B | NOK 985.66 | 0.36% down | 10% up | ||
| 97 | PfizerPFE · Health Care | +9.98% | NOK 1.52T | NOK 267.13 | 0.51% down | 10% up | ||
| 98 | Arrowhead PharmaceuticalsARWR · Health Care | +7.91% | NOK 57B | NOK 403.33 | 5.22% down | 8% up | ||
| 99 | Medpace HoldingsMEDP · Health Care | +7.12% | NOK 166.5B | NOK 5,952.40 | 3.70% down | 7% up | ||
| 100 | GE HealthCare TechnologiesGEHC · Health Care | +7.12% | NOK 355.5B | NOK 786.19 | 1.53% down | 7% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7494 NOK).
Questions and answers
Which health care companies in the United States rank first by one-year price change?
Moderna (+740%), Erasca (+387%) and Kodiak Sciences (+371%) are the top three of the 140 health care companies in the United States ranked by one-year price change as of 21 Nov 2026, 06:00 UTC.
How many health care companies in the United States are in this ranking?
140 are ranked by one-year price change.
What are these health care companies in the United States worth together?
The 140 health care companies in the United States ranked by one-year price change have a combined market value of NOK 71.18T as of 21 Nov 2026, 06:00 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies in the United States by one-year price change”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.